Translate page

English English
en Englishbg Bulgarianzh-CN Chinese (Simplified)hr Croatiancs Czechda Danishnl Dutchfi Finnishfr Frenchde Germanel Greekiw Hebrewhi Hindiid Indonesianit Italianja Japaneseko Koreanmk Macedonianpl Polishpt Portuguesero Romanianru Russiansr Serbiansk Slovaksl Slovenianes Spanishsv Swedishth Thaitr Turkishvi Vietnamese

iCMLf Forum

iCMLf Forum 2015 Webstreams

Forum 2015 Speakers red

Webstreams of the presentations from the iCMLf Forum for Physicians from Emerging Regions 2015 are now available to view. Presenters give the local perspectives on each topic followed by discussion with the audience and iCMLf experts.

View the practicalities of:

  1. Managing children with CML 
    Professor Deepak Bansal (India) and Professor Meinolf Suttorp (Germany)
  2. Practicalities treating CML with generic therapies 
    Dr Carolina Pavlovsky (Argentina) and Professor Jeff Lipton (Canada)
  3. Challenges with long term CML therapy
    Professor Qian Jiang (China) and Professor Michael Mauro (USA)

Click on the presentations below to view the webstreams and see the slides.
(We are very grateful for the support of Brandcast media to produce these web streams)  

 

 

Forum 2015 Bansal II red

Prof. Deepak Bansal
Chandigarh, India

Managing children with CML - Perspectives from India 

Topics include; treatment of children with CML in India, main characteristics of managing children with CML in India, key challenges to meet.

 

 

 

 

 

Forum 2015 Suttorp red

Prof. Meinolf Suttorp
Dresden, Germany

Managing children with CML 

Topics include; managing children with CML in Europe and globally, problems with adherence in adolescent patients, reducing side effects, applying adult CML scores to pediatric patients.

 

 

 

 

Forum 2015 Pavlovsky red

Dr Carolina Pavlovsky
Fundaleu, Argentina

The practicalities of treating CML with generic therapies -
Perspectives from Argentina

Topics include; generics in Argentina, responses in CML patients with generic therapy, adverse events in patients with generic imatinib, pro's/con's of non-branded drugs. 

 

 

 

 

Forum 2015 Lipton redProf. Jeff Lipton
Toronto, Canada

The practicalities of treating CML with generic therapies

- Experience and recommendations 

Topics include; experiences with generic TKI's in Canada, key recommendations for treating CML with generics.

 

 

 

 

 

Forum 2015 Jiang II redProf. Qian Jiang
Beijing, China

Challenges with long-term CML therapy - Perspectives from China

Topics include; CML therapy in China, patient-assistance programs, therapy goals & preference for discontinuing therapy, long-term CML therapy: issues & solutions. 

 

 

 

 

 

Forum 2015 Mauro red
Prof. Michael Mauro
New York, USA

Managing the 'c' in Chronic Myeloid Leukemia 

Topics include: putting CML response into perspective, putting CML cost into perspective, how close can we come with 'optimized' imatinib?, defining a standard of TKI discontinuation studies.